Featured video: Alzheimer’s treatment may be more effective for people at highest risk

Video abstract summarizing new research published in Molecular Neurodegeneration. "APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice” by Pankiewicz et al., 2017.


View all articles

View all articles



Guojun Bu, Mayo Clinic, USA
Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA

Aims and scope

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Read more

Impact Factor

Molecular Neurodegeneration has an Impact Factor of 6.510, meaning the journal is now the highest ranking open access neuroscience journal in the JCR.

Society partner

Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.

About BrightFocus | Research | Grants

News from Alzforum

View feed

Latest collections


Thematic series
Molecular Neurodegeneration
Basic biology and disease pathways

Molecular Neurodegeneration
Collection published: 12 September 2014

Cross journal collection
The gut-brain axis: Emerging evidence in health and disease
Collection published: 23 May 2014


Thematic series
Current concepts in Alzheimer's disease research: molecules, models and translational perspectives
Collection published: 22 October 2013

View all collections